NightHawk Biosciences, Inc. (NHWK)

NYSEAMERICAN: NHWK · IEX Real-Time Price · USD
2.27
-0.18 (-7.35%)
May 18, 2022 4:00 PM EDT - Market closed
Market Cap58.23M
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out25.65M
EPS (ttm)-1.41
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume75,158
Open2.49
Previous Close2.45
Day's Range2.22 - 2.49
52-Week Range1.60 - 10.85
Beta0.30
Analystsn/a
Price Target11.60 (+411.0%)
Earnings DateMay 18, 2022

About NHWK

Heat Biologics, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating platform that functions as an immune activator to stimulate and expand T-cells; and ComPACT, which delivers antigen driven T-cell activation and specific co-stimulation in a single product. The company develops HS-...

IndustryBiotechnology
IPO DateJul 24, 2013
CEOJeffrey Wolf
Employees49
Stock ExchangeNYSEAMERICAN
Ticker SymbolNHWK
Full Company Profile

Financial Performance

In 2021, NHWK's revenue was $2.11 million, a decrease of -28.33% compared to the previous year's $2.95 million. Losses were -$35.07 million, 34.6% more than in 2020.

Financial Statements

News

Heat Biologics Completes Name Change to NightHawk Biosciences; Trading to Commence Under “NHWK” Effective at the Mark...

DURHAM, N.C., May 03, 2022 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. / NightHawk Biosciences (NYSE American: HTBX; NHWK), a fully integrated biopharmaceutical company focused on developing first-in-class...

2 weeks ago - GlobeNewsWire

Heat Biologics (“NightHawk Biosciences”) Completes Acquisition of Elusys Therapeutics

Elusys becomes wholly-owned biodefense subsidiary of NightHawk

4 weeks ago - GlobeNewsWire

Heat Biologics Announces Planned Name Change to NightHawk Biosciences, Reflecting Company's Evolution, Therapeutic Pi...

Key Corporate Updates Announced Via Livestream Event from Manhattan, Kansas, available for replay at Nighthawkbio.com Key Corporate Updates Announced Via Livestream Event from Manhattan, Kansas, availab...

4 weeks ago - GlobeNewsWire